• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA IDL SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA IDL SET Back to Search Results
Catalog Number 10316
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190)
Patient Problem Reaction (2414)
Event Date 10/11/2019
Event Type  Injury  
Manufacturer Narrative
Investigation is in process.A follow-up report will be provided.
 
Event Description
An adverse event was reported related to a clinical study on white blood cell depletion (wbcd) using a spectra optia device.An increased ldh was reported in the patient.The patient was given methylprednisolone sodium succinate needle and calcium gluconate injection.The patient was reported as recovered.Patient age, weight, and gender are not available at this time.The disposable set is not available for return because it was discarded by the customer this product is not available within the us, but this report is being filed due to an alleged failure that could occur on a similarly marketed device platform cleared for use by the fda.
 
Event Description
The specific ldh result was not provided.In addition to increased ldh, test results indicated the subject had hypoalbuminemia and a decreased platelet count.Patient¿s gender and weight were obtained from the run data file (rdf).
 
Manufacturer Narrative
Investigation: the run data file (rdf) was analyzed for this event.The operator made no changes to the default packing factor or collect pump flow rate, and there were no excessive pump pauses during the run.No signs of aggregation were observed in the aim images.The collection preference (cp) varied from 65-78 for throughout the procedure.Lactic acid dehydrogenase (ldh) is an enzyme that helps produce energy.If ldh blood or fluid levels are high, it may mean certain tissues have been damaged by disease or injury.A normal ldh range in adults (blood) is 140-280 u/l.Disorders that cause high ldh levels include: anemia, kidney disease, liver disease, muscle injury, heart attack, pancreatitis, infections, including meningitis, encephalitis, and infectious mononucleosis (mono), and certain types of cancer, including lymphoma and leukemia.A higher than normal ldh level may also mean treatment for cancer is not working.A review of the device history record (dhr) for this unit showed no irregularities during manufacturing that were relevant to this issue.Investigation is in process.A follow up report will be provided.
 
Manufacturer Narrative
Investigation: a disposable history search of the lot number found no other reports of increased ldh levels.Per internal medical review and analysis, the device did not cause or contribute to this incident.Root cause: the specific root cause for the increase in ldh could not be determined.Based on literature and medical review, the increased ldh is likely related to the patient's disease progression.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA IDL SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
MDR Report Key10779122
MDR Text Key214397369
Report Number1722028-2020-00492
Device Sequence Number1
Product Code GKT
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,s
Type of Report Initial,Followup,Followup
Report Date 11/03/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/01/2021
Device Catalogue Number10316
Device Lot Number1902083130
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Initial Date Manufacturer Received 10/13/2020
Initial Date FDA Received11/03/2020
Supplement Dates Manufacturer Received03/05/2021
05/03/2021
Supplement Dates FDA Received03/17/2021
05/12/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age32 YR
Patient Weight72
-
-